首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

2076286

肛門裂傷治療市場：依治療方法、給藥途徑、通路和地區分類。

Anal Fissure Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，肛門裂傷治療市場在 2026 年將達到 12.155 億美元，預計到 2033 年將達到 17.681 億美元。預計從 2026 年到 2033 年，該市場將以 5.5% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	12.155億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.50%	2033年市場規模預測：	17.681億美元

肛門裂傷是一種常見疾病，影響著世界各地許多人。它指的是肛門黏膜上的細小撕裂或裂口，會導致不適、疼痛，有時還會在排便時出血。雖然肛門裂傷有時可以自行癒合，但通常需要治療來緩解症狀並促進癒合。

許多肛門裂傷會在幾週內自然癒合，但如果不癒合，則可能出現併發症。這種情況稱為慢性肛門裂傷不但不會癒合，反而會形成惡性循環，傷口不斷惡化，最後留下永久性疤痕。

肛門裂傷的症狀包括排便時疼痛、排便後持續數小時的疼痛、排便後糞便或廁所用衛生紙上有鮮紅色血液、肛門周圍皮膚有可見的撕裂，以及肛門裂傷附近皮膚上有小腫塊或隆起。

由於肛門裂傷在全球的發病率不斷上升，全球肛門裂傷治療市場正經歷顯著成長。久坐不動的生活方式、不良的飲食習慣以及人口老化等因素都導致了肛門裂傷率的上升。此外，人們對各種治療方案的認知不斷提高，以及對微創手術需求的成長，也進一步推動了市場成長。

市場動態：

全球肛門裂傷率的上升以及市場參與者不斷推出新產品，預計將推動預測期內市場成長。例如，根據2022年9月15日發表在《臨床醫學》雜誌上的數據，新墨西哥州一般人群的肛門裂傷年發生率為0.11%。

本研究的主要特點：

本研究對全球肛門裂傷治療市場進行了全面分析，包括市場規模和 2026 年至 2033 年預測期內的複合年成長率 (%)，以 2025 年為基準年。
本報告揭示了各個細分市場的潛在商機，並為該市場提供了一個具有吸引力的投資提案矩陣。
此外，它還提供了有關市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略的關鍵見解。
該報告還包括全球肛門裂傷治療市場主要參與者的簡介，重點介紹了他們的背景、產品系列、財務表現和策略。
本研究涵蓋的主要公司包括 Abvi、諾華製藥、梯瓦製藥、Troika、RDD Pharma Co., Ltd.、協和麒麟株式會社、Cipla、益普生製藥、賽諾菲、勃林格殷格翰國際有限公司、Bliss GVS、SRS Life Sciences、HealthyLife Pharma Private Limited 和 Jamcares。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊可以就產品發布、市場擴張和行銷策略做出明智的決策。
這份關於全球肛門裂傷治療市場的報告旨在為各種行業相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球肛門裂傷治療市場中使用的各種策略矩陣做出明智的決策。

市場動態
- 促進因素
  - 肛門裂傷率增加
  - 提高大眾意識並消除社會偏見
- 抑制因子
  - 社會禁忌阻礙人們尋求治療
  - 產品召回
- 機會
  - 新興國家市場規模龐大
  - 對微創手術的需求日益成長
影響分析
主要亮點
監管趨勢
產品上市及核准
PEST分析
波特五力分析
併購情景

第4章世界各國肛門裂傷的治療方法

供給面和需求面分析
經濟影響

第5章全球肛門裂傷治療市場：依治療類型分類，2021-2033年

瀉藥
局部硝酸鹽製劑
鈣離子通道阻斷劑
軟便劑
外科手術
其他

第6章全球肛門裂傷治療市場：依給藥途徑分類，2021-2033年

口服
外用
其他

第7章全球肛門裂傷治療市場：依通路分類，2021-2033年

醫院藥房
零售藥房
網路藥房

第8章全球肛門裂傷治療市場：依地區分類，2021-2033年

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

Abbvie
Novartis AG
Teva Pharmaceuticals
Troikaa
RDD Pharma, Ltd
Kyowa Kirin Co., Ltd
Cipla Inc.
Ipsen Pharma
Sanofi
Boehringer Ingelheim International GmbH
Bliss GVS
SRS Life Sciences
Healthy Life Pharma Private Limited
Geri-Care Pharmaceuticals Corp

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI6358

Anal Fissure Treatment Market is estimated to be valued at USD 1,215.5 Mn in 2026 and is expected to reach USD 1,768.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,215.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.50%	2033 Value Projection:	USD 1,768.1 Mn

Anal fissure is a common medical condition that affects a significant number of individuals worldwide. It refers to a small tear or cut in the lining of the anus, resulting in discomfort, pain, and sometimes bleeding during bowel movements. While anal fissures can heal on their own, it often require treatment to alleviate symptoms and promote healing.

Many anal fissures heal by themselves in a few weeks, but complications can develop when they don't. These are called chronic anal fissures. Instead of healing, they continue to reinforce themselves in a vicious cycle, leaving a persistent wound.

Symptoms of anal fissure includes; Pain during bowel movements, Pain after bowel movements that can last up to several hours, Bright red blood on the stool or toilet paper after a bowel movement, a visible crack in the skin around the anus, a small lump or skin tag on the skin near the anal fissure

Global anal fissure treatment market is witnessing significant growth due to increasing prevalence of anal fissures globally. Factors such as sedentary lifestyles, poor dietary habits, and rising aging population contribute to growing incidence of anal fissures. Rising awareness about the availability of various treatment options and increasing demand for minimally invasive procedures are further driving the market growth.

Market Dynamics:

Increasing prevalence of anal fissure globally and increasing product launches by the market players are expected to aid drive the market growth over the forecast period. For instance, on September 15, 2022, according to the data published by the Clinical Medicine, annual incidence of anal fissures in the general population is 0.11% in New Mexico.

Key Features of the Study:

This study provides a comprehensive analysis of the global anal fissure treatment market, including market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period of 2026-2033, with 2025 as the base year
The report elucidates potential revenue opportunities across different segments and offers attractive investment proposition matrices for this market
It provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
The profiles of key players in the global anal fissure treatment market are included, highlighting their company background, product portfolio, financial performance, and strategies
Key companies covered in this study include Abvie, Novartis AG, Teva Pharmaceuticals, Troikaa, RDD Pharma, Ltd, Kyowa Kirin Co., Ltd, Cipla Inc., Ipsen Pharma, Sanofi, Boehringer Ingelheim International GmbH, Bliss GVS, SRS Life Sciences, Healthy Life Pharma Private Limited, and Geri-Care Pharmaceuticals Corp
The insights from this report enable marketers and management authorities of companies to make informed decisions regarding product launches, market expansion, and marketing tactics
Global anal fissure treatment market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders can make informed decisions through different strategy matrices used in analyzing the global anal fissure treatment market

Anal Fissure Treatment Market Detailed Segmentation:

By Treatment Type (Revenue, USD Mn, 2021 - 2033)
Laxatives
Topical Nitrates
Calcium Channel Blockers
Stool Softeners
Surgery
Others
By Route of Administration (Revenue, USD Mn, 2021 - 2033)
Oral
Topical
Others
By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top companies in Global Anal Fissure Treatment Market
Abvie
Novartis AG
Teva Pharmaceuticals
Troikaa
RDD Pharma, Ltd
Kyowa Kirin Co., Ltd
Cipla Inc.
Ipsen Pharma
Sanofi
Boehringer Ingelheim International GmbH.
Bliss GVS
SRS Life Sciences
Healthy Life Pharma Private Limited
Geri-Care Pharmaceuticals Corp.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Anal Fissure Treatment Market, By Treatment Type
- Anal Fissure Treatment Market, By Route of Administration
- Anal Fissure Treatment Market, By Distribution Channel
- Anal Fissure Treatment Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Increasing Prevalence of Anal Fissures
  - Rising Awareness and Removing Social Stigma
- Restraints
  - Social Taboo Inhibiting Treatment Seeking
  - Product Recall
- Opportunities
  - Huge Scope in Emerging Economies
  - Growing Demand for Minimally Invasive Procedures
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER€(TM)s Analysis
Merger and Acquisition Scenario

4. Global Anal Fissure Treatment

Supply Side and Demand Side Analysis
Economic Impact

5. Global Anal Fissure Treatment Market, By Treatment Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Topical Nitrates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Calcium Channel Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Stool Softeners
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Anal Fissure Treatment Market, By Route of Administration, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€" 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

7. Global Anal Fissure Treatment Market, By Distribution Channel, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€" 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

8. Global Anal Fissure Treatment Market, By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - U.K.
  - Germany
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Abbvie
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Troikaa
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
RDD Pharma, Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Kyowa Kirin Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bliss GVS
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SRS Life Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Healthy Life Pharma Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Geri-Care Pharmaceuticals Corp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views